TUMARK® VISION FOR EVIVA® STANDARD
Report
- Report Number
- 3030927217-2025-00001
- Event Type
- Injury
- Date Received
- December 22, 2025
- Date of Event
- November 24, 2025
- Report Date
- December 22, 2025
- Manufacturer
- SOMATEX MEDICAL TECHNOLOGIES GMBH
- Product Code
- NEU
- UDI-DI
- 04250195611222
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
LOT NUMBER OF THE DEVICE NOT PROVIDED BY THE COMPLAINANT; THEREFORE, THE UDI, EXPIRATION AND MANUFACTURING DATES ARE NOT KNOWN. DEVICE HISTORY RECORD (DHR) REVIEW WAS UNABLE TO BE CONDUCTED FOR THE DISPOSABLE DEVICE AS THE IDENTIFICATION NUMBERS WERE NOT PROVIDED BY THE COMPLAINANT. THE DEVICE INVOLVED IN THIS EVENT WAS NOT RETURNED FOR EVALUATION PURPOSES THEREFORE VISUAL AND FUNCTIONAL ANALYSIS OF THE PRODUCT COULD NOT BE PERFORMED. WE ARE UNABLE TO CONFIRM A RELATIONSHIP BETWEEN THE DEVICE AND THE ISSUE REPORTED. THE INFORMATION OBTAINED DURING COMPLAINT INVESTIGATION WILL BE INCLUDED IN OUR GLOBAL COMPLAINT TRENDING AND PRODUCT SURVEILLANCE WILL CONTINUE TO MONITOR COMPLAINTS OF THIS TYPE FOR ADVERSE TRENDS. IF THE PRODUCT IS RECEIVED OR ADDITIONAL INFORMATION IS OBTAINED, THE INVESTIGATION WILL BE REOPENED ACCORDINGLY PER STANDARD OPERATING PROCEDURE.
IT WAS REPORTED THAT DURING AN VACUUM ASSISTED EXCISION OF A B3 LESION ON (B)(6) 2025, THE LESION CONTAINED A TUMARK ¨VISION¨BREAST MARKER. THE VACUUM ASSISTED EXCISION WAS PERFORMED USING A 7G BD ENCORE DEVICE. THE FACILITY REPORTED THAT THE MARKER WAS DAMAGED DURING THE PROCEDURE AND SEVERAL SMALL FRAGMENTS WERE LODGED WITHIN THE SURROUNDING BREAST TISSUE. NO OTHER INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2328483 | TUMARK® VISION FOR EVIVA® STANDARD | MARKER, RADIOGRAPHIC, IMPLANTABLE | NEU | SOMATEX MEDICAL TECHNOLOGIES GMBH | TUMARK-E13-S-VISION | 04250195611222 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Other |